Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Deferasirox on ferritin and iron overload in major thalassemia
IRCT2015071823245N1Phase 4Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of deferasirox in beta thalassemia major, sponsored by Golestan University of Medical Sciences. Primary endpoints: Change in serum ferritin and Change in overall iron overload. Started Oct 2014; status: completed.
02
Drugs
deferasirox
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on IRCT2015071823245N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015071823245N1.